Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

Remember, the best value phone is the one that you've got, and that works. If you'd really like to take fancy pictures or ...

About two months into what had been a rewarding “personal journey” in India, and after travelling through nearly a dozen ...